Retrophin Secures $24,916,307 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0bcc6ad1-8cc9-41dd-b563-e86eabe683a1
Date
10/8/2013
Company Name
Retrophin
Mailing Address
777 Third Avenue 22nd Floor New York, NY 10017
Company Description
Retrophin, LLC is a privately-held New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases.
Website
http://www.retrophin.com
Transaction Type
Venture Equity
Transaction Amount
$24,916,307
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
M&A Terms
Venture Investor
Undisclosed